找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Endoscopic Therapy for Barrett‘s Esophagus; Richard E. Sampliner Book 2009 Humana Press 2009 Ablation.Atmen.Endoscopic therapy.Esophagecto

[復(fù)制鏈接]
樓主: interminable
11#
發(fā)表于 2025-3-23 11:55:04 | 只看該作者
12#
發(fā)表于 2025-3-23 14:22:19 | 只看該作者
13#
發(fā)表于 2025-3-23 20:31:45 | 只看該作者
Multipolar Electrocoagulation (MPEC): An Early, Widely Available Technique,assessing its durability and the need for continued surveillance in successfully ablated patients, and evaluating whether ablation reduces the risk of subsequently developing adenocarcinoma are needed. Given these uncertainties, its use at present may best be limited to ablating residual short/limit
14#
發(fā)表于 2025-3-24 01:22:33 | 只看該作者
15#
發(fā)表于 2025-3-24 05:02:35 | 只看該作者
16#
發(fā)表于 2025-3-24 08:05:59 | 只看該作者
,New Technologies for Imaging of Barrett’s Esophagus,l fluorescent microscopy, spectroscopy and optical coherence tomography are reviewed. Unresolved issues for most of these technologies include regulatory approval, commercial availability and demonstration of clinical utility. This chapter reviews recent developments in endoscopy-based imaging modalities in patients with Barrett’s esophagus.
17#
發(fā)表于 2025-3-24 11:38:42 | 只看該作者
,Cryoablation of Barrett’s Esophagus,is now increasingly being evaluated for human use in the ablation of Barrett’s esophagus (BE), vascular abnormalities, and the treatment and palliation of gastric and esophageal malignancy. This chapter will focus on the application of this therapy for Barrett’s esophagus.
18#
發(fā)表于 2025-3-24 17:14:22 | 只看該作者
19#
發(fā)表于 2025-3-24 21:40:11 | 只看該作者
20#
發(fā)表于 2025-3-25 01:18:37 | 只看該作者
Decision Making in Ablation: Disease, Patients, and Institutional Factors,cosa. The patient’s life expectancy, comorbidity, adherence to endoscopy, and attitude toward cancer risk all have to be considered. Finally, the local expertise in histologic assessment, staging, and surgery needs to be taken into account in an extensive discussion of therapeutic options with the patient.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 10:58
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
富蕴县| 天峨县| 南召县| 水城县| 古田县| 论坛| 竹溪县| 冀州市| 贵南县| 沿河| 封开县| 锡林郭勒盟| 琼中| 星子县| 盖州市| 贞丰县| 桐梓县| 乌拉特前旗| 铜川市| 安多县| 镇平县| 兰考县| 石柱| 仪征市| 滦南县| 历史| 汕尾市| 平遥县| 东兴市| 东港市| 白玉县| 长乐市| 融水| 岳西县| 南川市| 深州市| 侯马市| 新余市| 忻城县| 南京市| 崇仁县|